Further to being awarded the honor of “Top National Innovator in Pharmaceutical R&D” for 9 consecutive years, ASK Pharm has also been recognized as one of the “Top 100 National Pharmaceutical Companies (2017)”. ASK Pharm was ranked in the 74th position, and it has received this title for 7 times.
According to data collected and reported by China National Pharmaceutical Industry Information Center (PHIIC), the requirements for “Top 100” ranking have become more competitive over the years, for example, the minimal annual corporate revenue required for 2017 ranking was increased to 2.56 billion RMB from 2.44 billion RMB (2016). Moreover, the national pharmaceutical industry has seen continuous opportunities and challenges in 2017, at the same time there has been extensive national and international exposure of problems associated with pharmaceutical quality and drug use safety. The government and regulatory agencies are also enforcing significant reform and transition of regulatory standardization and product innovation to meet the needs and demands for quality healthcare by the general public. The continued recognitions of ASK Pharm as a leading brank-name pharmaceutical company this year will aspire our endeavors in R&D innovation and quality pharmaceutical production, and contribute to the health and well-being of the society as well as the general public.
